Literature DB >> 2860938

Affinities of adrenergic drugs for alpha 2-adrenoceptors in dog saphenous vein in comparison with those in rat brain or human platelets.

K Sogabe, H Hashimoto, M Nakashima.   

Abstract

The affinities of drugs for the postsynaptic alpha 2-adrenoceptors in the dog saphenous vein were examined and compared with those in human platelets or in rat brain. The pA2 or pD2 values in the vein were determined in the presence of phenoxybenzamine. The pKi values (dissociation constant) of drugs for binding to alpha 2-adrenoceptors in human platelets or in rat brain were determined by radioligand binding assay using 3H-yohimbine (YOH) or 3H-clonidine (CLO) as ligands. The binding of agonists to 3H-YOH binding sites was carried out in the presence of GTP. The pA2 or pD2 values in the vein had a good correlation with pKi values for YOH sites but not with those for CLO sites in rat brain. The pKi values for YOH sites in human platelets had a good correlation with those for YOH sites in the brain or with pA2 or pD2 values in the vein. These results suggested that the affinities of adrenergic drugs for postsynaptic alpha 2-adrenoceptors in the dog saphenous vein are similar to those in brain and in platelets, and it is probable that the adrenergic drugs produce their alpha 2-adrenoceptor-mediated effects on vascular tissues primarily through binding to a low-affinity form of the alpha 2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860938     DOI: 10.1159/000158590

Source DB:  PubMed          Journal:  Blood Vessels        ISSN: 0303-6847


  1 in total

1.  Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.

Authors:  F Lanza; J P Cazenave; A Beretz; A Sutter-Bay; J G Kretz; R Kieny
Journal:  Agents Actions       Date:  1986-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.